About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,828 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,828 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5161-5180 of 10,828 trials

WithdrawnSwallowing Impairments in ICU Survivors and Community-Dwelling AdultsPost-intensive care syndrome (PICS), which consists of physical, cognitive, and psychosocial problems, is a pervasive complication for older intensive care unit (ICU) survivors…NCT07005037·Nashville, Tennessee CompletedA Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid MalignanciesThis is an open-label Phase 1a dose escalation study of single-agent OMP-52M51 in subjects with relapsed or refractory lymphoid malignancies.NCT01703572·La Jolla, California and 9 others CompletedVitamin D to Improve Outcomes by Leveraging Early TreatmentVitamin D deficiency is a common, potentially reversible contributor to morbidity and mortality among critically ill patients.NCT03096314·Fresno, California and 46 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

TerminatedT Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantRATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors predict whether patients undergoing donor stem cell transplant will develop acute…NCT00651716·Nashville, Tennessee

CompletedStudy of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic StrokeThe 2006 American Heart Association / American Stroke Association Council on Stroke Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic…NCT00924638·Mountain View, California and 54 others

CompletedA Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsThe main purpose of this study is to evaluate the safety and tolerability of anti-programmed cell death ligand 1 (PD-L1) checkpoint antibody LY3300054 in participants with…NCT02791334·Nashville, Tennessee and 13 others

CompletedDoxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial CancerThis randomized phase III trial compares how well two different combination chemotherapy regimens (doxorubicin hydrochloride, cisplatin, and paclitaxel versus carboplatin and…NCT00063999·Birmingham, Alabama and 649 others

CompletedDeveloping a Checklist of Lymphedema Symptoms in Patients With Head and Neck CancerRATIONALE: Developing a symptom checklist for late-effect lymphedema may help doctors learn more about lymphedema in patients with head and neck cancer and plan the best treatment.NCT00840814·Nashville, Tennessee and 2 others

CompletedInvestigating Biological Targets, Markers, and Intervention for Chronic PainThis multi-modal methods study will investigate neurophysiological, endocrinological, cognitive, psycho-social-emotional markers of chronic pain, and therapeutic targets using…NCT04625504·Nashville, Tennessee

CompletedSafety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's LymphomaSummary: As this is an open label study, all patients will receive SDX-105 by 30-60 minute intravenous infusion on day 1 and day 2. Treatment will repeat every 21 days.NCT00069758·Birmingham, Alabama and 16 others

RecruitingA Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)The purpose of the study is to assess the efficacy and safety of the addition of Tersolisib (LY4064809/STX-478) to other anti-cancer drugs as first treatment for advanced hormone…NCT07174336·Anchorage, Alaska and 362 others

CompletedPilot Study of Head Cooling in Preterm Infants With Hypoxic Ischemic EncephalopathyThe hypothesis is that premature infants' can have enough cooling applied to cool their brain to decrease CNS injury without cooling their body.NCT00620711·Nashville, Tennessee

CompletedDifferent Doses of Naronapride vs. Placebo in GastroparesisThis is a double-blind, randomized, multicenter, placebo-controlled, comparative phase II dose-finding trial.NCT05621811·Chula Vista, California and 23 others

TerminatedAn Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical PracticeThe purpose of this study is to explore the safety, efficacy, effects on quality of life (QOL), and biomarker response of ozanimod in participants with moderate to severely active…NCT05369832·Dothan, Alabama and 84 others

TerminatedAn Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's DementiaThe purpose of this study is to evaluate whether treatment with atabecestat slows cognitive decline compared with placebo treatment, as measured by a composite cognitive measure…NCT02569398·Birmingham, Alabama and 127 others

Enrolling by invitationOpen-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCMThe purpose of this study is to collect long-term safety and tolerability data for aficamten.NCT04848506·Birmingham, Alabama and 128 others

CompletedStudy of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative ColitisUlcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).NCT05570006·Chula Vista, California and 29 others

CompletedIbrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell TransplantThis phase II trial studies how well ibrutinib works in treating patients after a donor stem cell transplant for lymphoma that is not responding to treatment or has come back.NCT02869633·Birmingham, Alabama and 4 others

CompletedPrevention of Retained-Blood Outcomes With Active Clearance TechnologyPostoperative bleeding is a common consequence after heart surgery which can significantly impact outcomes and costs .NCT02145858·Manchester, New Hampshire and 1 other

CompletedOlopatadine Eye Drops and Allergy Skin TestingUse of olopatadine ophthalmic solution (eye drops) will decrease allergy skin test reactivity.NCT00775658·Nashville, Tennessee

PreviousPage 259 of 542Next

Diabetes

in Nashville

Heart Diseasein Nashville